bilobalide has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouaziz, N; Michiels, C; Quéré, L; Redon, M; Remacle, J | 1 |
| Bauer, R; Beubler, E; Dittrich, P; Feizlmayr, E; Pinl, F; Suter, A; Woelkart, K | 1 |
1 trial(s) available for bilobalide and cardiovascular agents
| Article | Year |
|---|---|
Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Topics: Adult; Biological Availability; Cardiovascular Agents; Chromatography, High Pressure Liquid; Cyclopentanes; Female; Furans; Ginkgo biloba; Ginkgolides; Humans; Lactones; Male; Mass Spectrometry; Phytotherapy; Plant Extracts; Tablets; Young Adult | 2010 |
1 other study(ies) available for bilobalide and cardiovascular agents
| Article | Year |
|---|---|
Mitochondrial respiratory chain as a new target for anti-ischemic molecules.
Topics: Adenosine Triphosphate; Animals; Bridged Bicyclo Compounds; Cardiovascular Agents; Cell Adhesion; Cell Hypoxia; Cell Survival; Cells, Cultured; Cyclopentanes; Diterpenes; Dose-Response Relationship, Drug; Electron Transport; Esters; Female; Furans; Ginkgolides; Humans; Ischemia; Malonates; Mitochondria, Liver; Neutrophils; Oxygen Consumption; Rats; Rats, Wistar; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |